Clinical management of venetoclax in multiple myeloma
Neomorphic mutations driving hematological cancers
Prospects of treating CLL and their complications
Big data on efficacy and toxicity levels for ibrutinib in CLL
Are prognostic factors the key to precision medicine in CLL?